Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Warfarin (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 18
» View wsbt.com items only
    May 15, 2013 |Story| Hartford Courant

  1. Pharmaceutical Firm's Growth Bucks State Trend

    At Boehringer Ingelheim Pharmaceuticals, the second-largest drug company in Connecticut, the local workforce increased by more than 40 percent over the last 10 years, at the same time its employee numbers worldwide grew by 35 percent.
    The Hartford Courant
    At Boehringer Ingelheim Pharmaceuticals, the second-largest drug company in Connecticut, the local workforce increased by more than 40 percent over the last 10 years, at the same time its employee numbers worldwide grew by 35 percent. A company that...

    Tags: Science, Research, Pradaxa (drug), Ridgefield, Science and Technology

    2. Apr 29, 2013 |Story| Los Angeles Times

  2. FDA approves a drug to reverse anticoagulation

    Ever since the drug warfarin was discovered to be a highly effective anti-clotting agent as well as a good rat poison in the early 1950s, it has been the frontline weapon in preventing stroke among those with atrial fibrillation. But its growing use has always raised the specter of dangerously hard-to-stanch bleeding if someone taking it is wounded or bleeds internally from a fall or a car accident.
    Ever since the drug warfarin was discovered to be a highly effective anti-clotting agent as well as a good rat poison in the early 1950s, it has been the frontline weapon in preventing stroke among those with atrial fibrillation. But its growing use has...

    Tags: Pradaxa (drug), Dietary Supplements, Food and Drug Administration, Rivaroxaban (drug), Physical Conditions

    3. Apr 25, 2013 |Story| Reuters

  3. Bristol-Myers Squibb sales disappoint, shares fall

    Reuters
    (Reuters) - Bristol-Myers Squibb reported disappointing first-quarter sales, prompting a drop in shares that have risen sharply this year on enthusiasm for its lineup of promising experimental drugs. The company on Thursday said sales plunged 27...

    Tags: Morningstar Incorporated, Avapro (drug), Rheumatoid Arthritis, High Blood Pressure, Credit Ratings

    4. Mar 14, 2013 |Story| Reuters

  4. Too many drug types are compromising heart health: doctors

    (Reuters) - About 80 million Americans suffer from heart disease, the nation's No. 1 killer, and most are on multiple drugs.
    Reuters
    (Reuters) - About 80 million Americans suffer from heart disease, the nation's No. 1 killer, and most are on multiple drugs. Some cardiologists think prescribing has gotten out of hand. The criticism was voiced by a number of leading heart doctors who...

    Tags: Hospitals and Clinics, Diabetes, New York University, Health and Safety at School, Heart Disease

    5. Nov 12, 2012 |Story| Reuters

  5. Cost becomes bigger question in treating heart disease

    LOS ANGELES (Reuters) - The cost of treating heart disease has become a key factor in decisions by U.S. cardiologists grappling with the nation's No. 1 killer.
    Reuters
    LOS ANGELES (Reuters) - The cost of treating heart disease has become a key factor in decisions by U.S. cardiologists grappling with the nation's No. 1 killer. Record prices for drugs and devices, reduced reimbursement by insurance plans and the...

    Tags: Hospitals and Clinics, Diabetes, Heart Disease, Health Organizations, Health Care Reform (2009)

    6. Oct 23, 2012 |Story| Reuters

  6. Green tea drinkers show lower cancer risks

    NEW YORK (Reuters Health) - Older women who regularly drink green tea may have slightly lower risks of colon, stomach and throat cancers than women who make no time for tea, a large study suggests.
    Reuters
    NEW YORK (Reuters Health) - Older women who regularly drink green tea may have slightly lower risks of colon, stomach and throat cancers than women who make no time for tea, a large study suggests. Researchers found that of more than 69,000 Chinese women...

    Tags: Dietary Supplements, Cancer, Physical Fitness and Exercise, Science and Technology, Vitamin K

    7. Aug 27, 2012 |Story| WDBJ7

  7. OUR HEALTH: They call them "strokes". I'm not sure why.

    <em>Darrell Laurant, the Lynchburg News &amp; Advance columnist, writer, and author, suffered a stroke on June 8. This is his story, written especially for Our Health.</em>
    Darrell Laurant, the Lynchburg News & Advance columnist, writer, and author, suffered a stroke on June 8. This is his story, written especially for Our Health. In its most common usage, the word "stroke" conjures images that are smooth and gentle --...

    Tags: Stroke, Physical Conditions, High Blood Pressure, Lynchburg (Lynchburg, Virginia), Diabetes

    8. May 4, 2012 | Allentown Morning Call

  8. LVH plays a role in aspirin-warfarin study

    Health
    Patients recruited through Lehigh Valley Hospital helped play a role in an important study published this week in the New England Journal of Medicine. The study took 10 years and was the largest double-blind comparison of aspirin and warfarin, a blood-...
    9. Jan 10, 2012 |Story| Los Angeles Times
  9. |Story
    10. Dec 30, 2011 |Story| Aberdeen News

  10. 'Tis the season for pets to encounter mouse poison

    Unless you live in northern Minnesota or the Black Hills, you've just enjoyed the opposite of a white Christmas. This has made life easier for people and animals in many ways. However, some animals are up to their normal routine whether snow is on the...

    Tags: Pets, Vomiting, Human Body, Human Body, Blood

    11. Nov 14, 2011 |Story| Reuters

  11. Doctors reserve judgment on new blood clot drugs

    ORLANDO, Florida (Reuters) - Cardiologists are not ready to jump to any conclusions about a closely-watched group of new blood thinners and said serious questions about their safety still need to be addressed.
    Reuters
    ORLANDO, Florida (Reuters) - Cardiologists are not ready to jump to any conclusions about a closely-watched group of new blood thinners and said serious questions about their safety still need to be addressed. Three new medicines that offer potential...

    Tags: Pradaxa (drug), Food and Drug Administration, Hospitals and Clinics, Social Sciences, Health

    12. Aug 28, 2011 |Story| Reuters

  12. New Bristol, Pfizer clot drug saves lives in study

    PARIS (Reuters) - An experimental anti-clotting drug from Bristol-Myers Squibb and Pfizer saved more lives than standard treatment warfarin in a major study, giving it an edge over rivals in an emerging multibillion-dollar market.
    Reuters
    PARIS (Reuters) - An experimental anti-clotting drug from Bristol-Myers Squibb and Pfizer saved more lives than standard treatment warfarin in a major study, giving it an edge over rivals in an emerging multibillion-dollar market. Although Eliquis will...

    Tags: Pennsylvania, Pradaxa (drug), Hospitals and Clinics, Physical Conditions, Duke University

 1  2 • Next >
Original site for Warfarin (drug) topic gallery.